ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 643006 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 643006; 2) Community: the network communities that were significantly associated with the response to NSC 643006; 3) Molecule: the relationships between components within communities and NSC 643006; 4) MDR: the compounds that were significantly associated with the NSC 643006.

NSC Compound Enrichment Correlation
NSC 343499 CI-921: amsacrine derivative 0.00286159651545688 0.58659744
NSC 52429 Null 0.00311117111817102 0.0055793726
NSC 628676 Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4-aminophenyl)amino]-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,5-dimethoxyphenyl)-, dihydrochloride 0.00311117111817102 0.55040975
NSC 709516 Null 0.00359493104490018 0.015606832
NSC 719735 Null 0.00359493104490018 -0.0098160819
NSC 363812 Tetraplatin 0.00359493104490023 0.31675294
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.00359493104490023 0.12602933
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.00404192617431249 0.13531284
NSC 634724 10,11-methylenedioxycamptothecin 0.00404192617431249 0.4556896
NSC 661746 2-Debenzoyl-2-(3',5'-difluorobenzoyl)-15(16)-anhydro-11(15->1)-abeotaxol 0.00404192617431249 0.22415827
Total:84  Current:8    [First] [Prev] [Next] [Last]